GSEA analysis suggested that RRM2-related genes were abundant in immune-related signals (B cell and BCR and complement system) and hallmarks of cancer processes (MAPK and NF-KB activation) in BRCA, LAML, LIHC, KIRC, KIRP and PRAD (Figure 6). The gene discussed is RRM2; the disease is cancer.